Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 15 November 1996:
Vol. 274. no. 5290, pp. 1197 - 1199
DOI: 10.1126/science.274.5290.1197
Prev | Table of Contents | Next

Reports

Mapping of a Gene for Parkinson's Disease to Chromosome 4q21-q23

Mihael H. Polymeropoulos, * Joseph J. Higgins, Lawrence I. Golbe, William G. Johnson, Susan E. Ide, Giuseppe Di Iorio, Giuseppe Sanges, Edward S. Stenroos, Lana T. Pho, Alejandro A. Schaffer, Alice M. Lazzarini, Robert L. Nussbaum, Roger C. Duvoisin

Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease, affecting approximately 1 percent of the population over age 50. Recent studies have confirmed significant familial aggregation of PD and a large number of large multicase families have been documented. Genetic markers on chromosome 4q21-q23 were found to be linked to the PD phenotype in a large kindred with autosomal dominant PD, with a Zmax = 6.00 for marker D4S2380. This finding will facilitate identification of the gene and research on the pathogenesis of PD.

M. H. Polymeropoulos, S. E. Ide, A. A. Schaffer, R. L. Nussbaum, Laboratory of Genetic Disease Research, National Center for Human Genome Research, National Institutes of Health, Bethesda, MD 20892-1430, USA.
J. J. Higgins and L. T. Pho, Clinical Neurogenetics Unit, Medical Neurology Branch, National Institutes of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1430, USA.
L. I. Golbe, W. G. Johnson, E. S. Stenroos, A. M. Lazzarini, R. C. Duvoisin, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.
G. Di Iorio and G. Sanges, Istituto di Scienze Neurologiche, Facoltá di Medicina, Seconda Universitá degli Studi di Napoli, Naples, Italy.
*   To whom correspondence should be addressed.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls.
J. Simon-Sanchez and A. B. Singleton (2008)
Hum. Mol. Genet. 17, 1988-1993
   Abstract »    Full Text »    PDF »
There Is No Parkinson Disease.
W. J. Weiner (2008)
Arch Neurol 65, 705-708
   Abstract »    Full Text »    PDF »
A genome scan in a single pedigree with a high prevalence of multiple sclerosis.
D A Dyment, M Z Cader, B M Herrera, S V Ramagopalan, S M Orton, M Chao, C J Willer, A D Sadovnick, N Risch, and G C Ebers (2008)
J. Neurol. Neurosurg. Psychiatry 79, 158-162
   Abstract »    Full Text »    PDF »
Present and future approaches to Parkinson disease: from molecular insights to new therapeutic avenues..
R. G. Fariello and A. Lieberman (2006)
Neurology 67, S1-S4
   Full Text »
Phenotypic commonalities in familial and sporadic Parkinson disease..
Y. Baba, K. Markopoulou, J. D. Putzke, N. R. Whaley, M. J. Farrer, Z. K. Wszolek, and R. J. Uitti (2006)
Arch Neurol 63, 579-583
   Abstract »    Full Text »    PDF »
Rapid Anionic Micelle-mediated {alpha}-Synuclein Fibrillization in Vitro.
M. Necula, C. N. Chirita, and J. Kuret (2003)
J. Biol. Chem. 278, 46674-46680
   Abstract »    Full Text »    PDF »
Parkin is recruited to the centrosome in response to inhibition of proteasomes.
J. Zhao, Y. Ren, Q. Jiang, and J. Feng (2003)
J. Cell Sci. 116, 4011-4019
   Abstract »    Full Text »    PDF »
Neuroprotection in PD--A role for dopamine agonists?.
A.H. V. Schapira (2003)
Neurology 61, S34-42
   Full Text »
Young-Onset Parkinson Disease With and Without Parkin Gene Mutations: A Fluorodopa F 18 Positron Emission Tomography Study.
S. Thobois, M.-J. Ribeiro, E. Lohmann, A. Durr, P. Pollak, O. Rascol, S. Guillouet, E. Chapoy, N. Costes, Y. Agid, et al. (2003)
Arch Neurol 60, 713-718
   Abstract »    Full Text »    PDF »
Genomic convergence: identifying candidate genes for Parkinson's disease by combining serial analysis of gene expression and genetic linkage.
M. A. Hauser, Y.-J. Li, S. Takeuchi, R. Walters, M. Noureddine, M. Maready, T. Darden, C. Hulette, E. Martin, E. Hauser, et al. (2003)
Hum. Mol. Genet. 12, 671-677
   Abstract »    Full Text »    PDF »
Haploinsufficiency at the {alpha}-synuclein gene underlies phenotypic severity in familial Parkinson's disease.
H. Kobayashi, R. Kruger, K. Markopoulou, Z. Wszolek, B. Chase, H. Taka, R. Mineki, K. Murayama, O. Riess, Y. Mizuno, et al. (2003)
Brain 126, 32-42
   Abstract »    Full Text »    PDF »
The genetic basis of Parkinson's disease.
T Foltynie, S Sawcer, C Brayne, and R A Barker (2002)
J. Neurol. Neurosurg. Psychiatry 73, 363-370
   Abstract »    Full Text »    PDF »
A multigenerational family with multiple sclerosis.
D. A. Dyment, M. Z. Cader, C. J. Willer, N. Risch, A. D. Sadovnick, and G. C. Ebers (2002)
Brain 125, 1474-1482
   Abstract »    Full Text »    PDF »
Linkage stratification and mutation analysis at the parkin locus identifies mutation positive Parkinson's disease families.
W C Nichols, N Pankratz, S K Uniacke, M W Pauciulo, C Halter, A Rudolph, P M Conneally, and T Foroud (2002)
J. Med. Genet. 39, 489-492
   Full Text »    PDF »
Neuroprotection and dopamine agonists.
A. H. V. Schapira (2002)
Neurology 58, S9-18
   Abstract »    Full Text »
Two large British kindreds with familial Parkinson's disease: a clinico-pathological and genetic study.
D. J. Nicholl, J. R. Vaughan, N. L. Khan, S. L. Ho, D. E. W. Aldous, S. Lincoln, M. Farrer, J. D. Gayton, M. B. Davis, P. Piccini, et al. (2002)
Brain 125, 44-57
   Abstract »    Full Text »    PDF »
Residual Structure and Dynamics in Parkinson's Disease-associated Mutants of alpha -Synuclein.
R. Bussell Jr. and D. Eliezer (2001)
J. Biol. Chem. 276, 45996-46003
   Abstract »    Full Text »    PDF »
Familial parkinsonism with synuclein pathology: Clinical and PET studies of A30P mutation carriers.
R. Kruger, W. Kuhn, K.L. Leenders, R. Sprengelmeyer, T. Muller, D. Woitalla, A.T. Portman, R.P. Maguire, L. Veenma, U. Schroder, et al. (2001)
Neurology 56, 1355-1362
   Abstract »    Full Text »    PDF »
AP-1 Repressor Protein JDP-2: Inhibition of UV-Mediated Apoptosis through p53 Down-Regulation.
F. Piu, A. Aronheim, S. Katz, and M. Karin (2001)
Mol. Cell. Biol. 21, 3012-3024
   Abstract »    Full Text »
Fate of Midbrain Dopaminergic Neurons Controlled by the Engrailed Genes.
H. H. Simon, H. Saueressig, W. Wurst, M. D. Goulding, and D. D. M. O'Leary (2001)
J. Neurosci. 21, 3126-3134
   Abstract »    Full Text »    PDF »
Human and Mouse alpha -Synuclein Genes: Comparative Genomic Sequence Analysis and Identification of a Novel Gene Regulatory Element.
J. W. Touchman, A. Dehejia, O. Chiba-Falek, D. E. Cabin, J. R. Schwartz, B. M. Orrison, M. H. Polymeropoulos, and R. L. Nussbaum (2001)
Genome Res. 11, 78-86
   Abstract »    Full Text »
Familial Aggregation of Parkinson's Disease in Iceland.
S. Sveinbjornsdottir, A. A. Hicks, T. Jonsson, H. Petursson, G. Guethmundsson, M. L. Frigge, A. Kong, J. R. Gulcher, and K. Stefansson (2000)
N. Engl. J. Med. 343, 1765-1770
   Abstract »    Full Text »    PDF »
Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese.
K. Gwinn-Hardy, J. Y. Chen, H.-C. Liu, T. Y. Liu, M. Boss, W. Seltzer, A. Adam, A. Singleton, W. Koroshetz, C. Waters, et al. (2000)
Neurology 55, 800-805
   Abstract »    Full Text »    PDF »
Hydrocarbon exposure and Parkinson's disease.
G. Pezzoli, M. Canesi, A. Antonini, A. Righini, L. Perbellini, M. Barichella, C. B. Mariani, F. Tenconi, S. Tesei, A. Zecchinelli, et al. (2000)
Neurology 55, 667-673
   Abstract »    Full Text »    PDF »
Molecular Etiology of Parkinson Disease: Recent Progress.
B. S. Shastry (2000)
Neuroscientist 6, 234-240
   Abstract »    PDF »
Contribution of Lewy Body Inclusions to Dementia in Patients With and Without Alzheimer Disease Neuropathological Conditions.
V. Haroutunian, M. Serby, D. P. Purohit, D. P. Perl, D. Marin, M. Lantz, R. C. Mohs, and K. L. Davis (2000)
Arch Neurol 57, 1145-1150
   Abstract »    Full Text »    PDF »
Clinical and genetic study of familial Parkinson's disease in Tunisia.
N. Gouider-Khouja, S. Belal, M. B. Hamida, and F. Hentati (2000)
Neurology 54, 1603-1609
   Abstract »    Full Text »    PDF »
Dementia Associated With Lewy Bodies: Dilemmas and Directions.
M. F. Weiner (1999)
Arch Neurol 56, 1441-1442
   Full Text »    PDF »
PET studies of parkinsonism associated with mutation in the {alpha}-synuclein gene.
A. Samii, K. Markopoulou, Z. K. Wszolek, V. Sossi, T. Dobko, E. Mak, D. B. Calne, and A. J. Stoessl (1999)
Neurology 53, 2097
   Abstract »    Full Text »    PDF »
The genetics of disorders withsynuclein pathology and parkinsonism.
M. Farrer, K. Gwinn-Hardy, M. Hutton, and J. Hardy (1999)
Hum. Mol. Genet. 8, 1901-1905
   Abstract »    Full Text »    PDF »
Neuropsychological abnormalities in first degree relatives of patients with familial Parkinson's disease.
K. Dujardin, A. Duhamel, E. Becquet, C. Grunberg, L. Defebvre, and A. Destee (1999)
J. Neurol. Neurosurg. Psychiatry 67, 323-328
   Abstract »    Full Text »
Inheritance of Frontotemporal Dementia.
T. W. Chow, B. L. Miller, V. N. Hayashi, and D. H. Geschwind (1999)
Arch Neurol 56, 817-822
   Abstract »    Full Text »    PDF »
Molecular Basis of the Neurodegenerative Disorders.
J. B. Martin (1999)
N. Engl. J. Med. 340, 1970-1980
   Full Text »    PDF »
Acute and reversible parkinsonism due to organophosphate pesticide intoxication: Five cases.
M. H. Bhatt, M. A. Elias, and A. K. Mankodi (1999)
Neurology 52, 1467
   Abstract »    Full Text »
Understanding Parkinson Disease.
J. L. Cummings (1999)
JAMA 281, 376-378
   Full Text »    PDF »
Lack of mutation G209A in the alpha -synuclein gene in French patients with familial and sporadic Parkinson's disease.
G LUCOTTE, G MERCIER, and J C TURPIN (1998)
J. Neurol. Neurosurg. Psychiatry 65, 948-949
   Full Text »
The G209A Mutation in the {alpha}-Synuclein Gene Is Not Detected in Familial Cases of Parkinson Disease in Non-Greek and/or Italian Populations.
W. W. Wang, M. Khajavi, B. J. Patel, J. Beach, J. Jankovic, and T. Ashizawa (1998)
Arch Neurol 55, 1521-1523
   Abstract »    Full Text »    PDF »
The role of the alpha -synuclein gene mutation in patients with sporadic Parkinson's disease in the United Kingdom.
T T Warner and A H V Schapira (1998)
J. Neurol. Neurosurg. Psychiatry 65, 378-379
   Abstract »    Full Text »
The familial parkinsonism locus on chromosome 4 and idiopathic Parkinson's disease in Japan.
T. KIMPARA, A. TAKEDA, N. OKITA, S. TAKASE, H. SAITO, and Y. ITOYAMA (1998)
J. Neurol. Neurosurg. Psychiatry 64, 416-417
   Full Text »
Aggregation of Neurofilament and {alpha}-Synuclein Proteins in Lewy Bodies: Implications for the Pathogenesis of Parkinson Disease and Lewy Body Dementia.
J. Q. Trojanowski and V. M.-Y. Lee (1998)
Arch Neurol 55, 151-152
   Full Text »    PDF »
A Gene for Parkinson Disease.
T. N. Chase (1997)
Arch Neurol 54, 1156-1157
   Abstract »    PDF »
Genetic Complexity and Parkinson's Disease.
W. K. Scott, J. M. Stajich, L. H. Yamaoka, M. C. Speer, J. M. Vance, A. D. Roses, M. A. Pericak-Vance, n. the Deane Laboratory Parkinson Disease Research Gr, T. Gasser, B. Müller-Myhsok, et al. (1997)
Science 277, 387-390
   Full Text »
Preventing the Extinction of the Clinical Research Ecosystem.
J. N. Thompson and J. Moskowitz (1997)
JAMA 278, 241-245
   Abstract »    PDF »
Mutation in the alpha -Synuclein Gene Identified in Families with Parkinson's Disease.
M. H. Polymeropoulos, C. Lavedan, E. Leroy, S. E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, et al. (1997)
Science 276, 2045-2047
   Abstract »    Full Text »
Medical Genetics.
C. T. Caskey (1997)
JAMA 277, 1869-1870
   PDF »
Neurology.
R. J. Joynt and R. M. Kurlan (1997)
JAMA 277, 1873-1874
   PDF »
A gene for Parkinson's disease?.
C. Hawkes (1996)
BMJ 313, 1278
   Full Text »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)